TM6SF2: Catch-22 in the fight against nonalcoholic fatty liver disease and cardiovascular disease?

Gastroenterology

Volumn 148, Issue 4, 2015, Pages 679-684

  Kahali, Bratati ^a   Liu, Yang Lin ^b   Daly, Ann K ^b   Day, Christopher P ^b   Anstee, Quentin M ^b   Speliotes, Elizabeth K ^c  

^a UNIVERSITY OF MICHIGAN   (United States)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; GLUCOSE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VERY LOW DENSITY LIPOPROTEIN; MEMBRANE PROTEIN; TM6SF2 PROTEIN, HUMAN;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ALLELE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; DISEASE ASSOCIATION; EXOME; FATTY LIVER; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GLUCOSE BLOOD LEVEL; HUMAN; IN VITRO STUDY; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN SECRETION; LIVER CIRRHOSIS; LIVER FIBROSIS; NONALCOHOLIC FATTY LIVER; NOTE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; TM6SF2 GENE; CHROMOSOME 19; GENETICS; METABOLIC SYNDROME X;

CARDIOVASCULAR DISEASES; CHROMOSOMES, HUMAN, PAIR 19; HUMANS; MEMBRANE PROTEINS; METABOLIC SYNDROME X; NON-ALCOHOLIC FATTY LIVER DISEASE; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84925357379     PISSN: 00165085     EISSN: 15280012     Source Type: Journal    
DOI: 10.1053/j.gastro.2015.01.038     Document Type: Editorial

References (31)

1. P. Dietrich, and C. Hellerbrand Non-alcoholic fatty liver disease, obesity and the metabolic syndrome Best Pract Res Clin Gastroenterol 28 2014 637 653
2. Q.M. Anstee, G. Targher, and C.P. Day Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis Nat Rev Gastroenterol Hepatol 10 2013 330 344
3. J.M. Clark The epidemiology of nonalcoholic fatty liver disease in adults J Clin Gastroenterol 40 Suppl 1 2006 S5 S10
4. R. Hernaez, J. McLean, and M. Lazo Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey Clin Gastroenterol Hepatol 11 2013 1183 1190 e2
5. E.K. Speliotes, J.M. Massaro, and U. Hoffmann Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study Hepatology 51 2010 1979 1987
6. J.D. Browning, L.S. Szczepaniak, and R. Dobbins Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity Hepatology 40 2004 1387 1395
7. S.A. Harrison, and B.A. Neuschwander-Tetri Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis Clin Liver Dis 8 2004 861 879
8. T. Review, D.R. LaBrecque, and Z. Abbas World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis J Clin Gastroenterol 48 2014 467 473
9. M. Hamaguchi, T. Kojima, and N. Takeda The metabolic syndrome as a predictor of nonalcoholic fatty liver disease Ann Intern Med 143 2005 722 728
10. J. Wang, S. Ruotsalainen, and L. Moilanen The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns Eur Heart J 28 2007 857 864
11. J.B. Schwimmer, M.A. Celedon, and J.E. Lavine Heritability of nonalcoholic fatty liver disease Gastroenterology 136 2009 1585 1592
12. E.K. Speliotes, L.M. Yerges-Armstrong, and J. Wu Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits PLoS Genet 7 2011 e1001324
13. Q.M. Anstee, and C.P. Day The genetics of NAFLD Nat Rev Gastroenterol Hepatol 10 2013 645 655
14. S. Romeo, J. Kozlitina, and C. Xing Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease Nat Genet 40 2008 1461 1465
15. Y.L. Liu, G.L. Patman, and J.B. Leathart Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma J Hepatol 61 2014 75 81
16. L. Valenti, A. Al-Serri, and A.K. Daly Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease Hepatology 51 2010 1209 1217
17. A. Gorden, R. Yang, and L.M. Yerges-Armstrong Genetic variation at NCAN locus is associated with inflammation and fibrosis in non-alcoholic fatty liver disease in morbid obesity Hum Hered 75 2013 34 43
18. T.M. Teslovich, K. Musunuru, and A.V. Smith Biological, clinical and population relevance of 95 loci for blood lipids Nature 466 2010 707 713
19. Global Lipids Genetics Consortium C.J. Willer, E.M. Schmidt, and S. Sengupta Discovery and refinement of loci associated with lipid levels Nat Genet 45 2013 1274 1283
20. J. Kozlitina, E. Smagris, and S. Stender Exome-wide association study identifies a TM6SF2 variant that confers susceptibility to nonalcoholic fatty liver disease Nat Genet 46 2014 352 356
21. Y.L. Liu, H.L. Reeves, and A.D. Burt TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease Nat Commun 5 2014 4309
22. P. Dongiovanni, S. Petta, and C. Maglio Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease Hepatology 61 2015 506 514
23. O.L. Holmen, H. Zhang, and Y. Fan Systematic evaluation of coding variation identifies a candidate causal variant in TM6SF2 influencing total cholesterol and myocardial infarction risk Nat Genet 46 2014 345 351
24. A.P. Morris, B.F. Voight, and T.M. Teslovich Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes Nat Genet 44 2012 981 990
25. H. Mahdessian, A. Taxiarchis, and S. Popov TM6SF2 is a regulator of liver fat metabolism influencing triglyceride secretion and hepatic lipid droplet content Proc Natl Acad Sci U S A 111 2014 8913 8918
26. P. Blattmann, C. Schuberth, and R. Pepperkok RNAi-based functional profiling of loci from blood lipid genome-wide association studies identifies genes with cholesterol-regulatory function PLoS Genet 9 2013 e1003338
27. V.W. Wong, G.L. Wong, and C.H. Tse Prevalence of the TM6SF2 variant and non-alcoholic fatty liver disease in Chinese J Hepatol 61 2014 708 709
28. S. Sookoian, G.O. Castano, and R. Scian Genetic variation in TM6SF2 and the risk of nonalcoholic fatty liver disease and histological disease severity Hepatology 61 2015 515 525
29. N.D. Palmer, S.K. Musani, and L.M. Yerges-Armstrong Characterization of European ancestry nonalcoholic fatty liver disease-associated variants in individuals of African and Hispanic descent Hepatology 58 2013 966 975
30. M. Ekstedt, L.E. Franzen, and U.L. Mathiesen Long-term follow-up of patients with NAFLD and elevated liver enzymes Hepatology 44 2006 865 873
31. Y. Zhou, G. Llauradó, and M. Oresic Circulating triacylglycerol signatures and insulin sensitivity in NAFLD associated with the E167K variant in TM6SF2 J Hepatol 62 2015 657 663